• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » NIHR invests $23.4M in pediatrics research

NIHR invests $23.4M in pediatrics research

May 31, 2016
CenterWatch Staff

A significant number of children experience long-term health conditions. This group’s health needs have not previously been given the research priority that they deserve. The NIHR has invested £21 million ($23.4 million) in 35 new studies focusing on improving the health outcomes for children and young people.

Professor Tom Walley, director of NIHR Evaluation Trials and Studies Programs, said, “This was a key part of the NIHR’s response to the need for more research-based evidence on the treatment of long-term conditions in children and young people. We must look at how we can improve the health of this group—there is strong evidence that early intervention can have a significant long-term impact on the patient, and economically. So this was not just a one off funding opportunity, but signals an ongoing NIHR interest in this essential area.”

Projects underway include: assessment of a new treatment for young people with a progressive long term eye disorder, keratoconus; drug therapy for attention deficit-hyperactivity disorder in young offenders; improving childhood atopic eczema through prevention, education and therapy; ensuring equal access to high quality hospital care and services for children and young people with learning disability and their families; and a trial assessing the safety and efficacy of flucloxacillin as a long-term treatment for infants with cystic fibrosis.

Royal College of Paediatrics and Child Health president, professor Neena Modi, said, "Infants, children, and young people deserve high quality healthcare and health services. In 2012 in our report “Turning the Tide,” we showed how under-represented infants, children and young people are in research that is essential both to evaluate existing treatments, services and policies, as much as to develop new treatments, medications and health promotion measures.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing